Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
6.03
-0.11 (-1.79%)
At close: May 17, 2024, 4:00 PM
6.00
-0.03 (-0.50%)
After-hours: May 17, 2024, 7:30 PM EDT
Lantern Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lantern Pharma stock has a target of 11, which predicts an increase of 82.42% from the current stock price of 6.03.
Analyst Consensus: Buy
* Price targets were last updated on Aug 10, 2023.
Analyst Ratings
The average analyst rating for Lantern Pharma stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 25, 2024 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +82.42% | Aug 10, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +82.42% | Jun 26, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +82.42% | May 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates n/a | Hold | Initiates | n/a | n/a | May 18, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.06
from -1.47
EPS Next Year
-1.95
from -2.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 4.1M | 15.3M | 35.5M |
| Avg | n/a | n/a | 4.0M | 14.9M | 34.5M |
| Low | n/a | n/a | 3.8M | 14.3M | 33.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 285.4% | 138.3% |
| Avg | - | - | - | 274.4% | 131.5% |
| Low | - | - | - | 259.7% | 122.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.08 | -1.90 | -1.59 | -1.34 | -0.80 |
| Avg | -2.06 | -1.95 | -1.54 | -1.31 | -0.78 |
| Low | -2.02 | -1.98 | -1.48 | -1.25 | -0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.